← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2004Last known activity
Aug 22, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05460416Lead sponsorPhase 4Aug 22, 2022
- NCT05460416Overall official - principal investigatorPhase 4Aug 22, 2022
- NCT05460416Reponsible party - principal investigatorPhase 4Aug 22, 2022
- NCT05097261CollaboratorPhase 4Sep 6, 2021
- NCT05038410Overall official - principal investigatorN/AApr 30, 2021
- NCT02227823Lead sponsorPhase 2Jul 1, 2014
- NCT02227823Reponsible party - principal investigatorPhase 2Jul 1, 2014
- NCT01849016CollaboratorPhase 3Apr 1, 2013
- NCT00557817Overall official - principal investigatorPhase 2/Phase 3Mar 1, 2004
Details
- Last known activity
- Aug 22, 2022